Industry

 

EKOS (a BTG group company)

Mike Wolniewicz, VP Engineering

​

Todd Schwoerer, Director of Instrument Development

The EkoSonic® Endovascular system uses targeted ultrasonic waves in combination with clot-dissolving drugs to effectively target an dissolve entire blood clots.

​

Philips Ultrasound

Rob Entrekin, Technical Fellow

Clinical Science for General Imaging.

​

Jeff Powers, Principal Scientist

I received a PhD in EE with specialty in medical ultrasound from UW in 1980.  I've worked at ATL / Philips ever since, pioneering the development of color flow and contrast imaging and now investigating minimally invasive therapy with ultrasound and microbubbles.

​

Abbott

Curt Fiore, Regional Sales Director

​

Jim Lewis, Therapy Development Specialist

​

Aortica Corporation

Shannon Eubanks, VP Engineering and Operations

Aortica Corporation was founded to create tools to advance the treatment of complex abdominal aortic aneurysm (AAA) disease.  We’re a small, "startup" team committed to setting and meeting aggressive goals. Shannon is a dynamic and creative technical leader with extensive experience developing and commercializing innovative medical devices.  Shannon has an engineering background, with a talent for rapid product development and team leadership.

​

MyoKardia, Inc.

Hector  Rodriguez, Senior Director of Research Biology

MyoKardia, Inc. is pioneering a precision medicine approach to discover, develop and commercialize targeted therapies for the treatment of serious and neglected rare cardiovascular diseases.

​

Sarah MacInnes, Scientist

We are developing drugs to treat genetic heart disease

​

Product Creation Studio

Scott Thielman, CTO

We support medtech innovators with product development services. Typically we have a big impact as technologies translate from research to commercialization.

​

Stratos

Wallace White, Director, Point-of-Care Diagnostics, Stratos Product Development

Stratos helps major companies and startups develop technologies into great medical devices and consumer products.

​

Medtronic

Michael Brown, Principal Scientist

​

Frank Coccarro, Regional Sales Manager

​

Precision Image Analysis

Mary Waiss, CEO

      

Novuson Surgical Inc.      

Francesco Curra, CTO 

​

Lawrence Livermore Labs    

Tom O'Hara, Postdoctoral Research Staff 

​

Scienega

Christian Burks, Principal

PhD on molecular etiology of cardiovascular disease. Now advising, consulting for and serving as director for early stage biotech start-ups.

​

Aqueduct Critical Care, Inc.

Tom Clement, CEO

I've spent my career developing medical devices and companies.  I have helped develop multiple catheters for Interventional Cardiology.

                                                               

Clinical Labs

 

Vascular Imaging Lab 

Tom Hatsukami, Professor, UW Division of Vascular Surgery

​

Jie Sun, Acting Instructor

​

David Dichek Laboratory

David Dichek, Professor of Medicine

My laboratory develops gene therapy for treating and preventing atherosclerosis. We are currently carrying out preclinical studies in rabbits.

​

Nagadhara Dronadula, Acting Instructor 

 

Cardiac Cath Labs

Jamie McCabe, Medical Director

UW Interventional cardiologist focused on circulatory support for shock, coronary stent procedures and valve replacements

 

UW Cardiology

Gabriel Aldea, Professor and chief of cardiac surgery, UW chief cardiac surgery; Professor of cardiac surgery, Co-director of heart center, co director of our catheter based valve Rx team.

​

Michael Chin, Harold T. Dodge / John L. Locke Chair in Cardiovascular Medicine, Founder and CEO, TransCellular Therapeutics.   

​

Claudius Mahr, Clinical Associate Professor of Medicine and Cardiac Surgery     

    

Robb MacLellan, Division Head, Cardiology, Center for Cardiovascular Biology.

​

Dmitry Levin, Research Scientist/Engineer, Center for CardioVascular Innovation.

           

UW Medicine Heart Regeneration Program

Scott Thies, Direct of Operations

As Director of Operations, I am responsible for overseeing the development of a human pluripotent stem cell-derived cardiomyocyte therapy through early clinical testing, and positioning this program to launch as a startup biotech company.                         

                                                    

Bioengineering Labs

 

Mike Averkiou, Associate Professor

My lab develops imaging and therapy ultrasound methods and technology to address medical problems in oncology and cardiology. 

​

Michael Regnier, Professor and Vice-Chair for Research

Our research group works to understand the mechanistic basis of inheritable diseases and develop targeted approaches to treating heart failure.

​

Ying Zheng, Assistant Professor

My lab works on vascular engineering, aiming to develop tools for better mimicking human vasculature for regeneration and disease modeling.

​

Jen Davis, Assistant Professor

Our lab works on the cellular and molecular underpinnings of cardiac remodeling and wound healing.

​

UW Relations and External Entrepreneur/Investor groups                                                

University of Washington

Terry Grant, Director, Industry Relations

     

UW Dept of Bioengineering

Kaitlin Colleary, Asst. Director, Advancement

​

UW College of Engineering

Valerie Overlan, Associate Director, Corporate Relations

​

UW Medicine Advancement

John Laughlin. Chair of the Heart Health Campaign Council

​

Anne Aumell, Director for Philanthropy

I serve as the Advancement officer for the Division of Cardiology and the Heart Health Campaign Priority with Dr. Robb MacLellan and John Laughlin, Campaign Chair.

​

WRF Capital/Washington Research Foundation 

Will Canestaro, Manager, Strategic Investments

​

New Business Acquisitions, USI

Malcolm Witter, Senior Director